Inhibiting miR-196 or miR-21 reduced LSCs in an experimental model of human MLL [56], miR-126 reduction reduced AML growth, and overexpression of some miRNAs induced murine leukemic transformation [44, 57]. The gene discussed is KMT2A; the disease is acute myeloid leukemia.